Cefdinir
Product Images NDC 10544-194

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 10544-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mg 20ct (Label Cefdinir Caps 300mg Bpi(10544 194 20) Aurobindo(65862 177 60) Rev2)

300mg 20ct (Label Cefdinir Caps 300mg Bpi(10544 194 20) Aurobindo(65862 177 60) Rev2)
Cefdinir Capsules 300 mg label by Blenheim Pharmacal, Inc. The label indicates each capsule contains 300 mg of Cefdinir, with a package count of 20 capsules. It includes storage instructions for controlled room temperature and highlights the prescription-only status. The label shows the NDC 10544-194-20 and manufacturing lot details.*
FDA Label Image

Structure (Cefdinir Str)

Structure (Cefdinir Str)
Chemical structure of Cefdinir, showing its molecular arrangement including rings, functional groups, and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.